December 2015

Nurses can access the collective knowledge of their peers, engage in discussions, and participate in collaborative projects whenever and wherever they like.

Coordination of care and educating patients and their caregivers needs to be the standard of care.

Supporting patients and families with a truly holistic and healing approach.

FDA approval of two immunotherapies to treat non-small cell lung cancer (NSCLC), an ever-expanding understanding of the disease’s molecular differences, and new screening guidelines for high-risk patients to detect lung cancer at an earlier, more treatable stage, are helping patients live longer.

One of the most difficult challenges oncology clinicians face is helping patients to manage the interplay of strong and often conflicting emotions that come with a difficult prognosis.

Superior sulcus tumors make up less than 5% of non–small cell lung cancers (NSCLC) but are associated with a number of debilitating symptoms that are particularly challenging to treat.

Navigation is an essential component of quality care for patients with lung cancer and their family caregivers, and the Bonnie J. Addario Lung Cancer Foundation (ALCF) is working to improve lung cancer outcomes through its Community Hospital Center of Excellence (COE) program.

Patients with lymphedema may significantly reduce their chances of skin infection and lower their healthcare costs with an advanced pneumatic compression device (APCD), a newly published study has found.

What a year it has been for FDA approvals in oncology! With the holidays upon us, there is much to be thankful for in the world of cancer research, where advances in understanding tumor biomarkers have ushered in a host of new personalized therapies for many patients.

One of the great mysteries in oncology practice is the return of breast cancer many years after its initial diagnosis and treatment. And by many years, I mean 15 or even 20 years later, at a time when a woman least expects it to return.